A generalizable pre-clinical research approach for orphan disease therapy

Beaulieu, C. L., Samuels, M. E., Ekins, S., McMaster, C. R., Edwards, A. M., Krainer, A. R., Hicks, G. G., Frey, B. J., Boycott, K. M., Mackenzie, A. E. (June 2012) A generalizable pre-clinical research approach for orphan disease therapy. Orphanet J Rare Dis, 7. pp. 1750-1172. ISSN 1750-1172 (Electronic)1750-1172 (Linking)

[thumbnail of Paper]
Preview
PDF (Paper)
Krainer Orphanet Journal of Rare Diseases 2012.pdf - Published Version

Download (701kB) | Preview
URL: http://www.ncbi.nlm.nih.gov/pubmed/22704758
DOI: 10.1186/1750-1172-7-39

Abstract

ABSTRACT: With the advent of next-generation DNA sequencing, the pace of inherited orphan disease gene identification has increased dramatically, a situation that will continue for at least the next several years. At present, the numbers of such identified disease genes significantly outstrips the number of laboratories available to investigate a given disorder, an asymmetry that will only increase over time. The hope for any genetic disorder is, where possible and in addition to accurate diagnostic test formulation, the development of therapeutic approaches. To this end, we propose here the development of a strategic toolbox and preclinical research pathway for inherited orphan disease. Taking much of what has been learned from rare genetic disease research over the past two decades, we propose generalizable methods utilizing transcriptomic, system-wide chemical biology datasets combined with chemical informatics and, where possible, repurposing of FDA approved drugs for pre-clinical orphan disease therapies. It is hoped that this approach may be of utility for the broader orphan disease research community and provide funding organizations and patient advocacy groups with suggestions for the optimal path forward. In addition to enabling academic pre-clinical research, strategies such as this may also aid in seeding startup companies, as well as further engaging the pharmaceutical industry in the treatment of rare genetic disease.

Item Type: Paper
Subjects: diseases & disorders
Investigative techniques and equipment
CSHL Authors:
Depositing User: Matt Covey
Date: June 2012
Date Deposited: 31 Jan 2013 21:16
Last Modified: 19 Jul 2021 20:17
PMCID: PMC3458970
Related URLs:
URI: https://repository.cshl.edu/id/eprint/26897

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving